AliveCor QT Service
Overview
The AliveCor QT Service (often utilized via the InstantQT software and K1000 or KardiaMobile 6L devices) is a point-of-care cardiac safety solution designed to measure and monitor QT and corrected QT (QTc) intervals in seconds. By utilizing AI-enabled, machine learning-powered ECG sensors, the service allows healthcare professionals to evaluate patients for potentially dangerous changes in cardiac activity without requiring a traditional, complex 12-lead ECG setup.
This service is primarily designed for:
- Psychiatrists and Mental Health Professionals: To screen and monitor patients prescribed psychotropic medications known to cause QT prolongation.
- Oncologists and Infectious Disease Specialists: To manage cardiac safety for patients on therapies with known cardiotoxic or QT-prolonging side effects.
- Clinical Trial Sponsors and Biopharma Partners: To integrate decentralized cardiac safety monitoring and real-world evidence collection into drug development pipelines.
In a clinical workflow, the service eliminates the need for external cardiology referrals for routine QT screening. Clinicians or patients can capture a medical-grade, 6-lead ECG in 30 seconds. The integrated software instantly processes the rhythm, calculates the QTc interval, and flags potential prolongations. This rapid assessment supports immediate clinical decision-making, accelerates therapy starts, and enhances patient safety during ongoing medication titration.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Cloud-based Software as a Medical Device (SaMD)
- Measures QT and QTc intervals (Bazett's and Fridericia's formulas)
- Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L)
- Prescription (Rx) use only, for qualified healthcare professionals
- Utilizes AI and deep neural networks for ECG analysis
- Provides instant QT measurements (as InstantQT)
- Integrates with KardiaStation app and KardiaPro portal
- API available for integration with EHR, SDK, CRM, EDC, and PSP platforms
- Secure, unlimited cloud storage for ECG data
- Supports remote ECG recording and monitoring
Use Cases
- Screening for QT prolongation before prescribing or titrating QT-prolonging medications (e.g., antipsychotics, certain antibiotics, cancer therapies)
- Monitoring cardiac safety in clinical trials and drug development
- Identifying patients at risk for Torsades de Pointes (TdP) and sudden cardiac death
- Supporting rapid clinical decision-making at the point of care
- Remote patient monitoring of cardiac health
- Integration into existing practice workflows and EHR systems
What Physicians Need to Know
Utilize AliveCor QT Service for rapid, in-office or remote assessment of QT/QTc intervals, especially when prescribing or titrating QT-prolonging medications to mitigate the risk of Torsades de Pointes. The KardiaMobile 6L device offers a convenient, less intrusive method for ECG recording compared to traditional 12-lead ECGs, improving patient comfort and compliance. Leverage its arrhythmia detection capabilities for early identification of common cardiac rhythm abnormalities. Integrate the service with existing EHR systems via KardiaPro for streamlined data management and enhanced patient monitoring.
AliveCor QT Service integrates with the KardiaMobile 6L device for ECG acquisition. Data can be managed through the KardiaPro web portal and offers robust integration options including EHR integration, SDKs for mobile app developers, and APIs for seamless data import into various enterprise systems. This facilitates automated ECG data transfer, secure storage, and workflow efficiency within clinical practices.
Details
| Category | Cardiology AI, Pharmacology & Dosing AI |
| Pricing | Contact vendor for pricing details. |
| Deployment | Cloud-based (Software as a Medical Device). Accessed over the internet. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated The AliveCor QT Service received FDA 510(k) clearance (K212662) on April 26, 2022. It is cleared as a cloud-based Software as a Medical Device (SaMD) to measure QT and QTc intervals from AliveCor-designed 6-Lead ambulatory ECG devices for prescription use by qualified healthcare professionals. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine |
What the Web Says
The AliveCor QT Service, utilizing the KardiaMobile 6L device, offers a portable and efficient solution for QT interval screening, particularly beneficial for patients on QT-prolonging medications. It aims to streamline the process of obtaining ECGs in-office, potentially reducing treatment delays and improving patient outcomes. While generally praised for its ease of use and accuracy in detecting certain arrhythmias, some users and healthcare professionals have raised concerns about its limitations compared to a 12-lead ECG, potential for false positives, and customer service issues.
Overall: MixedStrengths
- Easy to use and portable, making it convenient for in-office or at-home use.
- Provides rapid detection of abnormal QTc intervals and various arrhythmias like atrial fibrillation, bradycardia, and tachycardia.
- Can reduce the need for frequent conventional 12-lead ECGs, especially in resource-limited settings, saving time and costs.
- Offers a clinician ECG review service by board-certified cardiologists for detailed analysis within 24 hours.
- Helps in monitoring patients on QT-prolonging medications, potentially preventing dangerous side effects.
- Integration options with EHR and a web-based portal (KardiaPro) for managing patient data.
Limitations
- Does not replace a 12-lead ECG and may miss certain cardiac events or conditions like heart attacks.
- Can be prone to artifact and may not always provide a clear reading.
- Some users report issues with device reliability, connectivity, and battery life.
- Customer service has been a significant concern for some users, with reports of unresponsiveness and difficulty with returns.
- The intermittent nature of the device may not be sufficient for detecting all paroxysmal or silent arrhythmias.
- Subscription required for full access to features and detailed arrhythmia detection beyond basic AFib screening.
Based on reviews from: AliveCor, Fierce Biotech, YouTube (iMedicalApps Editor and Physician Cardiologist Satish Misra), iMedicalApps, JAMAnetwork.com, NCBI (National Center for Biotechnology Information), Trustpilot, Mayo Clinic, PMC (PubMed Central), The Skeptical Cardiologist, Best Buy, Reddit, WorthEPenny, Natural Rhythm Nutrition
Last updated: 2026-07-17
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AliveCor QT Service
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for AliveCor QT Service.
Revolutionising ECG Monitoring in Mental Health with KardiaMobile 6-Lead Device
Kardia by AliveCor
AliveCor Vic Gundrota featured on CNBC to discuss latest collaboration with Mayo Clinic
Kardia by AliveCor
How Accurate Is the AliveCor KardiaMobile 6-Lead EKG Monitor?
Limitless Body: Calisthenics, Bodyweight & HomeGym
Advancing Antipsychotic Monitoring: 5 Years of Success with KardiaMobile 6L #KM6L #ECG #QTmonitoring
Kardia by AliveCor
Improving Clinical Efficiency with KardiaMoile 6-Lead ECG: A Case Study #KM6L #ECG #QT_monitoring
Kardia by AliveCor
Kardia mobile device #ekg #cardiac
Leonard i
Frequently Asked Questions
Compare AliveCor QT Service
VS
VS
VS
VS
Investors who backed AliveCor QT Service
Funded through the company that built this tool.
